Do infection rates vary by age? In this article, RGA's Global Data and Analytics team studies estimates of pandemic experience in Spain and England so far, and uncovers remarkable differences. However, insurers need to bear in mind that these trends may look very d... Read More

The future of the COVID-19 pandemic is certainly muddy, with ongoing implications for claimant mental health, rehabilitation prospects, and claims duration. RGA's Dr. Adela Osman and Belinda Thorpe ask "How deep is the mud?" in the June 2020 edition of FA News.... Read More

Recently, a novel Kawasaki-like disease has been described as an emerging consequence of the COVID-19 infection. However, the association requires further investigation to better clarify the mechanisms behind this relationship. RGA's Dr. Paul Davis reviews the latest re... Read More

RGA's Colin DeForge considers what underwriters know and don’t know in the midst of the COVID-19 pandemic and offers practical steps on how to prevent fraudsters from taking advantage of this climate of uncertainty. 

This article is Part II in a series...

Read More

Chase Huey of RGAX, RGA’s transformation engine, explains how the implementation of the lean methodology can optimize processes and improve project success rates during the COVID-19 crisis.

Read More

The International Insurance Society (IIS) 55^th Global Insurance Forum attracts a diverse delegation of global insurance and reinsurance executives, regulators, academics and policymakers to discuss the issues that are shaping the future of the ins...

Read More

The past several decades have seen microbes become increasingly resistant to the modern arsenal of antimicrobial drugs, even as few new antimicrobial drugs have been discovered or developed. Against this backdrop, the drug-resistant fungus Candida auris (C. auris...

Read More

Who is at greatest risk of dying with COVID-19? One of the oldest mathematical formulations in actuarial science offers clues. RGA's Global Research and Data Analytics team demystifies the math behind current risk assessments by age and other factors. For more on this t... Read More

Are men dying from COVID-19 at a consistently higher rate? What is the relationship between the case fatality rate and age? RGA’s Global Research and Data Analytics team delves deep into publicly available data by age and sex, weighing country-specific uncertainties and... Read More

Could mental health be a casualty of quarantine and self-isolation measures aimed at curtailing the spread of COVID-19? RGA's Diana Bosworth explores rising reports of stress, anxiety, and depression, and identifies insurance product innovations aimed at helpi... Read More

Could the early 20th century remedy of plasma transfusions help fight the 21st century scourge of COVID-19? Dr. Jeffrey P. Henderson of Washington University is seeking to find out. The  Read More

How are life and health carriers responding to the pandemic? After performing a global review, RGA identifies six primary product development trends to watch. Read More

As the world looks forward to a return to normalcy, indications are that the pandemic will have lasting impact even after the immediate crisis is over. RGA’s Matthew Easley offers suggestions on how companies can approach the longer-term financial implications of the...

Read More

Explore the important and growing world of hematopoietic stem cell transplantation in ReFlections. HSCT is the standard of care for many hematological malignancies and has found new utility in the treatment of immunological and hereditary conditions. 

Read More

Head and neck cancers were the eighth most common cancers worldwide in 2018 and accounted for 3% of all cancer diagnoses and about 1.5% of cancer deaths in the U.S. alone. Epidemiologist Dr. Lauren Garfield discusses well known and emerging risk factors, survival rat...

Read More

Post-human underwriting? In On the Risk, RGA's Dr. Dihui Lai discusses the current state of artificial intelligence and the potentia... Read More

Over the past three decades, the global prevalence of diabetes has risen to record levels. There has been a corresponding increase in the use of the glycated hemoglobin A1c (HbA1c) test to assess or detect diabetes. An increasing number of underwriters are now also c...

Read More

As the COVID-19 pandemic continues to spread worldwide, we are seeing healthcare delivery disrupted in unprecedented ways as public health authorities implement measures to limit close contact, movement, and travel. RGA's Dr. Steve Woh surveys the landscape, from&nbs...

Read More

Could claims evolution be the right response to today's revolutionary change? RGA's Marilda Kotze identifies three simultaneous evolutions – across regulation, evidence gathering, and client engagement – that insurers should consider.  Read More

Does the COVID-19 pandemic represent the perfect storm for cancer patients? Not only are many sufferers at increased risk of severe consequences from the virus, but the spread of COVID-19 has also reduced access to screening and care, observes RGA's Hilary Henly. She...

Read More